- Investor's Business Daily•40 minutes ago
Bristol-Myers Squibb and Celgene stocks rocketed Thursday after the biotechs reported Q3 metrics that swept expectations.
- Reuters•1 hour ago
U.S. stocks dipped in a choppy session after the latest round of earnings reports, as a decline in the consumer discretionary sector and interest-rate sensitive stocks outweighed gains in healthcare names. About 7.2 billion shares changed hands in U.S. exchanges, above the 6.35 billion daily average over the last 20 sessions.
Celgene Corporation (CELG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||104.34 x 100|
|Ask||104.96 x 100|
|Day's Range||101.67 - 106.12|
|52wk Range||93.05 - 128.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||44.27|
|Avg Vol (3m)||3,940,790|
|Dividend & Yield||N/A (N/A)|